In addition, the GlyA showed better discriminating power by ROC curves (AUC = 0.663) (Fig. 5) in the patients with postpartum hemorrhage than in the patients with the rest adverse outcomes (ROC data not shown). The gene discussed is SHMT2; the disease is postpartum hemorrhage.